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Rebecca L Batten1* and Wan-Fai Ng2Abstract
Introduction: We report an unusual case of facial pain and swelling caused by compression of the facial and
vestibulocochlear cranial nerves due to the tortuous course of a branch of the posterior inferior cerebellar artery.
Although anterior inferior cerebellar artery compression has been well documented in the literature, compression
caused by the posterior inferior cerebellar artery is rare. This case provided a diagnostic dilemma, requiring
expertise from a number of specialties, and proved to be a learning point to clinicians from a variety of
backgrounds. We describe the case in detail and discuss the differential diagnoses.
Case presentation: A 57-year-old Caucasian woman with a background of mild connective tissue disease presented
to our rheumatologist with intermittent left-sided facial pain and swelling, accompanied by hearing loss in her left ear.
An autoimmune screen was negative and a Schirmer’s test was normal. Her erythrocyte sedimentation rate was
6mm/h (normal range: 1 to 20mm/h) and her immunoglobulin G and A levels were mildly elevated. A vascular
loop protocol magnetic resonance imaging scan showed a loop of her posterior inferior cerebellar artery taking a
long course around the seventh and eighth cranial nerves into the meatus and back, resulting in compression of
her seventh and eighth cranial nerves. Our patient underwent microvascular decompression, after which her symptoms
completely resolved.
Conclusion: Hemifacial spasm is characterized by unilateral clonic twitching, although our patient presented with
more unusual symptoms of pain and swelling. Onset of symptoms is mostly in middle age and women are more
commonly affected. Differential diagnoses include trigeminal neuralgia, temporomandibular joint dysfunction, salivary
gland pathology and migrainous headache. Botulinum toxin injection is recognized as an effective treatment option
for primary hemifacial spasm. Microvascular decompression is a relatively safe procedure with a high success rate.
Although a rare pathology, posterior inferior cerebellar artery compression causing facial pain, swelling and hearing loss
should be considered as a differential diagnosis in similar cases.
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Vascular compressionIntroduction
Hemifacial spasm (HFS) due to vascular loop compres-
sion of the seventh cranial nerve at the root exit zone at
the cerebellopontine angle has been well documented
[1]. HFS is characterized by unilateral clonic twitching,
initially affecting the orbicularis oculi muscle then pro-
gressing to the paranasal and perioral muscles [2]. It is* Correspondence: rebecca.batten@newcastle.ac.uk
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unless otherwise stated.the result of erratic nerve conduction and hyperstimula-
tion of the facial nerve nucleus [3].
Onset of symptoms is between 30 and 70 years of age,
mostly in middle age, and women are more commonly af-
fected. One study reported that 72% of patients with HFS
were female. Out of 74 patients, 17.5% reported concur-
rent auditory and vestibular symptoms [4]. Wang and
Jankovic found that the left side was affected in 56% of
patients, and bilateral HFS was rare [5].
Occasionally, patients exhibit symptoms of trigeminal
neuralgia, HFS and glossopharyngeal involvement. Thisal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Batten and Ng Journal of Medical Case Reports 2014, 8:105 Page 2 of 3
http://www.jmedicalcasereports.com/content/8/1/105is recognized as combined hyperactive dysfunction syn-
drome, and affected 2.8% of patients in one case review
[6]. Patients with this combination tend to be older
(mean age 66.6 years), again with a female predomin-
ance. Aging and hypertension accelerate the progressive
arteriosclerotic vasculoarchitechtural changes that occur
within the vertebrobasilar system [6].
Case presentation
A 57-year-old woman presented in 1995 with a six-week
history of acute onset polyarthralgia. She also had Ray-
naud’s phenomenon, dry eyes, dyspepsia, intermittent
night sweats, brittle nails, intermittent hair loss, mouth ul-
cers and fatigue. A provisional diagnosis of mild connect-
ive tissue disease (Sjögren’s or lupus) was made, based on
her symptoms and a single positive doubled-stranded de-
oxyribonucleic acid (DNA) result.
Her past medical history included Hashimoto’s thy-
roiditis and osteoarthritis. In 2007, she was infected with
a sheep bot fly while in Morocco. She subsequently had
larvae removed from her left maxillary sinus and her
right eye by our ear, nose and throat team.
In 2010, she re-presented to our rheumatology depart-
ment with intermittent left-sided facial pain and swell-
ing, accompanied by hearing loss in her left ear. She also
described gradually worsening epiphora, blepharospasm
and left eye swelling.
An autoimmune screen was negative, including anti-
Ro and anti-La, anti-neutrophil cytoplasmic antibodies,
autoantibody and antinuclear antibodies. Her erythro-
cyte sedimentation rate was 6mm/h (normal range: 1 to
20mm/h) and her levels of immunoglobulin G and A
were mildly elevated. A Schirmer’s test was also normal.
In view of these results, it was felt that her symptoms
were unlikely to be due to connective tissue disease.
Magnetic resonance imaging (MRI) of her sinuses, skull
base and parotid glands showed only mild thickening of
her sinuses. She was referred to our ear, nose and throat
team for further investigation. A tympanogram demon-
strated low tone loss and negative pressure. An ultrasound
scan of the left side of her face found no cause for the
swelling, and a flexible naso-endoscopy was normal.
In 2012, our patient was referred to our ophthalmol-
ogy team because of the persisting symptoms. She had
been started on carbamazepine and botulinum toxin in-
jections to her facial muscles, with minimal symptomatic
improvement. A second MRI scan was performed and
reviewed by a neuroradiologist. This scan suggested vas-
cular compression of her left facial nerve. A vascular
loop protocol MRI showed a loop of her posterior infer-
ior cerebellar artery taking a long course around the sev-
enth and eighth cranial nerves into the meatus and back,
resulting in compression of her seventh and eighth cra-
nial nerves.Our patient was referred to our neurosurgical team for
microvascular decompression. Her symptoms of pain,
epiphora, blepharospasm and swelling completely re-
solved following this procedure.
Discussion
Compression of the seventh and eighth nerves charac-
teristically results in HFS and vestibular and auditory
symptoms. Our patient presented with facial swelling
and pain as her main symptoms. To the best of our
knowledge, swelling associated with HFS has been docu-
mented in the literature only once: this case report sug-
gested that the underlying mechanism was persistent
clonic contractions hindering venous and lymphatic re-
turn, thus causing persistent swelling [7].
Facial pain due to trigeminal nerve vascular compres-
sion has been well documented, however the imaging in
our patient did not identify any trigeminal nerve path-
ology, despite its anatomical proximity to the seventh
nerve root exit zone. It is possible that the pain our pa-
tient was describing was geniculate neuralgia - a result
of compression of the nervus intermedius, which travels
between the seventh and eighth cranial nerves.
Secondary causes of HFS include tumor, trauma, de-
myelinating lesions, arteriovenous malformation and
aneurysm at the cerebellopontine angle. However, a sec-
ondary cause is rare, occurring in only 0.5% of patients
in one large (1,642 patients) case review [8].
The differential diagnosis to be considered in patients
who present with facial pain and swelling is wide-
ranging. Temporomandibular joint dysfunction is com-
monly associated with rheumatic disease. Clinical fea-
tures include restricted maximal mouth opening, locking
or dislocation, crepitation, masticatory muscle tender-
ness, and restricted laterotrusion [9].
Sensory trigeminal neuropathy presents with unilateral
or bilateral facial numbness, paresthesia, dysesthesia, or
pain, with a slowly progressive course. It has been recog-
nized as a presenting feature of mixed connective tissue
disease [10], systemic lupus erythematosus and Sjögren’s
syndrome [11].
Salivary gland pathology due to hyposalivation is a
recognized feature of connective tissue disease, and in-
cludes salivary gland infection, parotid necrosis, sub-
mandibular lymphadenopathy and primary salivary
gland lymphoma. Focal sialadenitis due to Sjögren’s
syndrome (primary or secondary) presents with in-
creased oral caries, oral dryness, candida infection, dif-
ficulty tolerating oral prostheses and facial pain. It is
recognized in up to 90% of patients with mixed con-
nective tissue disease [11].
Migrainous headache has also been well documented
in a number of connective tissue diseases, including sys-
temic lupus erythematosus and Sjögren’s syndrome [11].
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fection of the sinuses, which complicated the investiga-
tion and diagnosis, but was an important differential to
exclude as a cause of her facial pain.
Imaging of the posterior fossa structures is ideally per-
formed under MRI vascular loop protocol. One study
reviewed 83 patients with evidence of root exit zone
seventh cranial nerve compression on MRI, and found that
only 16% were symptomatic [12]. This suggests that inter-
vention should be guided by symptoms rather than radio-
logic findings alone. Another study reviewed MRI of 74
patients with symptoms of HFS and found that imaging
findings had no impact on patient management, as most
had symptom resolution with botulinum A toxin treatment.
This suggests that where resources are limited, imaging
may be reserved for patients with red flag or non-resolving
symptoms [4].
Botulinum toxin injection is recognized as an effective
treatment option for primary HFS, with an excellent
safety and tolerability profile [13]; however, our patient
did not receive any benefit from this treatment. The evi-
dence for the role of botulinum toxin in secondary HFS
is limited due to the rarity of the condition. A recent
case report suggests that it is an effective treatment op-
tion in secondary HFS [14].
Hyun et al. performed a prospective study of micro-
vascular decompression of HFS in 1,174 operations. Of
these, 94.1% of patients were cured of their symptoms
and 5.9% had residual spasm. Complications included
transient hearing loss (2.6%), permanent hearing loss
(1.1%), transient facial weakness (7.6%), permanent facial
weakness (0.7%), cerebrospinal fluid leakage (0.25%), and
cerebellar hemorrhage or infarction (0.17%). There were
no operative deaths [15]. Overall, this is a relatively safe
procedure with a high success rate.
Conclusion
We highlight the complexity of diagnosing facial pain in a
patient with connective tissue disease, caused by the variety
of orofacial manifestations of disease. In this case it was the
role of the rheumatologist to exclude an underlying inflam-
matory cause of our patient’s pain prior to referring her for
further investigation. Primary and secondary HFS are rare
but important causes of facial pain to consider, because sur-
gical intervention is generally safe with good outcomes.
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